NO20090279L - Fremgangsmater og farmasoytiske preparater for a medvirke til behandlingen av kjemoterapi-indusert nevropati - Google Patents

Fremgangsmater og farmasoytiske preparater for a medvirke til behandlingen av kjemoterapi-indusert nevropati

Info

Publication number
NO20090279L
NO20090279L NO20090279A NO20090279A NO20090279L NO 20090279 L NO20090279 L NO 20090279L NO 20090279 A NO20090279 A NO 20090279A NO 20090279 A NO20090279 A NO 20090279A NO 20090279 L NO20090279 L NO 20090279L
Authority
NO
Norway
Prior art keywords
chemotherapy
treatment
methods
pharmaceutical preparations
assist
Prior art date
Application number
NO20090279A
Other languages
English (en)
Norwegian (no)
Inventor
Luigi Lenaz
Guru Reddy
Dorla Mirejovsky
Original Assignee
Spectrum Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Spectrum Pharmaceuticals Inc filed Critical Spectrum Pharmaceuticals Inc
Publication of NO20090279L publication Critical patent/NO20090279L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays or needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO20090279A 2006-08-01 2009-01-19 Fremgangsmater og farmasoytiske preparater for a medvirke til behandlingen av kjemoterapi-indusert nevropati NO20090279L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US82108206P 2006-08-01 2006-08-01
PCT/US2007/075008 WO2008017000A2 (en) 2006-08-01 2007-08-01 Methods and pharmaceutical preparations for contributing to the treatment of chemotherapy-induced neuropathy

Publications (1)

Publication Number Publication Date
NO20090279L true NO20090279L (no) 2009-02-26

Family

ID=38744846

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20090279A NO20090279L (no) 2006-08-01 2009-01-19 Fremgangsmater og farmasoytiske preparater for a medvirke til behandlingen av kjemoterapi-indusert nevropati

Country Status (12)

Country Link
EP (1) EP2046335A2 (enExample)
JP (1) JP2009545619A (enExample)
KR (1) KR20090047501A (enExample)
CN (1) CN101657199A (enExample)
BR (1) BRPI0715504A2 (enExample)
CA (1) CA2659477A1 (enExample)
IL (1) IL196824A0 (enExample)
MX (1) MX2009001116A (enExample)
NO (1) NO20090279L (enExample)
RU (1) RU2009107123A (enExample)
WO (1) WO2008017000A2 (enExample)
ZA (1) ZA200900728B (enExample)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002004448A2 (en) * 2000-07-07 2002-01-17 Neotherapeutics, Inc. Methods for treatment of drug-induced peripheral neuropathy and related conditions

Also Published As

Publication number Publication date
BRPI0715504A2 (pt) 2014-05-06
EP2046335A2 (en) 2009-04-15
IL196824A0 (en) 2009-11-18
RU2009107123A (ru) 2010-09-10
MX2009001116A (es) 2009-02-10
CA2659477A1 (en) 2008-02-07
KR20090047501A (ko) 2009-05-12
WO2008017000A3 (en) 2008-03-20
WO2008017000A8 (en) 2009-04-30
ZA200900728B (en) 2010-03-31
CN101657199A (zh) 2010-02-24
JP2009545619A (ja) 2009-12-24
WO2008017000A2 (en) 2008-02-07

Similar Documents

Publication Publication Date Title
CY1113074T1 (el) Αντισωματα και ανοσοσυζευγματα και χρησεις αυτων
NO20090305L (no) Cyklosporin formuleringer
NO20170633A1 (no) Forbindelser av indolamin-2,3-dioksygenase for anvendelse i behandling av kreft i kombinasjon med et anti-PD-1 antistoff .
EA200870019A1 (ru) Лактамовые соединения и способы их применения
CY1114926T1 (el) Αντισωματα και ανοσοσυζευγματα και χρησεις αυτων
LTPA2017009I1 (lt) Brutono tirozinkinazės inhibitoriai
EA201590833A1 (ru) Антитела для лечения и профилактики болезни альцгеймера и их применение
NO20084356L (no) Anti TAT226-antistoffer og immunokonjugater
BR112012015721A2 (pt) modificação covalente de proteínas dirigida por ligante
CY1112383T1 (el) Αναστολεις της πρωτεϊνης ενεργοποιησης της 5-λιποξυγενασης (flap)
EA200900040A1 (ru) Молекулы антител, которые связываются с человеческим il-17
EA200870185A1 (ru) Комбинации ингибиторов ang2 и vegf
EA200801164A3 (ru) Ингибиторы протеина, активирующего 5-липоксигеназу (flap)
EP2061456A4 (en) COMPOSITIONS AND METHODS FOR INHIBITING P450 CYTOCHROME
DK2013166T3 (da) N-carbamoylmethyl-4(R)-phenyl-2-pyrrolidon, fremgangsmåde til fremstilling heraf og farmaceutisk anvendelse
DE602008003199D1 (de) Glucoseisomerase zur behandlung von fructose-unverträglichkeit
MA32321B1 (fr) Pregn-4-en-21, 17 carbolactones substitués sur le noyau c, et préparations pharmaceutiques contenant ces derniers
NO20073454L (no) Påvisning og kvantifisering av cyklodekstriner
TNSN08385A1 (en) Delayed-release glucocorticoid treatment of rheumatoid disease
NO20073772L (no) Preparater som omfatter et epotilon, og fremstillingsfremgangsmate
EA200870148A1 (ru) Производные сулиндака, их применение и получение
EA200701072A1 (ru) Препараты бензотиазола и их применение
WO2008017000A8 (en) Methods and pharmaceutical preparations for contributing to the treatment of chemotherapy-induced neuropathy
EA200870597A1 (ru) Фармацевтическое применение белковых молекул, иммунологически взаимосвязанных с дифтерийным токсином
UA110458C2 (ru) Інгібітори ns5a вгс

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application